Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present uniQure N.V. (NASDAQ: QURE).

Full DD Report for QURE

You must become a subscriber to view this report.


Recent News from (NASDAQ: QURE)

uniQure Announces Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 and Confirms Dose for AMT-061 Pivotal Study in Hemophilia B
-- Clinical Benefit of AMT-060 Maintained in All Patients Through up to Two and a Half Years of Follow-up – -- Second Dose Cohort Demonstrated a 93% Reduction in FIX Replacement Therapy Usage During Last Twelve Months of Observation, with Annualized Bleeds Near Zero -- -- Dose Conf...
Source: Thomson Reuters ONE
Date: December, 03 2018 07:00
uniQure beats by $0.10, misses on revenue
uniQure (NASDAQ: QURE ): Q3 GAAP EPS of -$0.59 beats by $0.10 . More news on: uniQure N.V., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 07:21
uniQure Announces Third Quarter 2018 Financial Results and Highlights Company Progress
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 06, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the third quarter of 2018 an...
Source: GlobeNewswire
Date: November, 06 2018 07:00
uniQure to Host Research & Development Day on Monday, November 19 in New York City
~ Event to be Webcast Live on Corporate Website ~ LEXINGTON, Mass and AMSTERDAM, the Netherlands, Nov. 05, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
Source: GlobeNewswire
Date: November, 05 2018 07:00
uniQure to Participate in Multiple Upcoming Industry Conferences
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming co...
Source: GlobeNewswire
Date: October, 31 2018 07:00
Achillion Appoints Paul Firuta Chief Operating Officer
NEW HAVEN, Conn., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Paul Firuta to the position of Executive Vice President and Chief Operating Officer effective immediately. Mr. Firuta, with 27 years of experience success...
Source: GlobeNewswire
Date: September, 10 2018 06:00
Gene therapy players under pressure
The Nasdaq's selloff notwithstanding, most gene therapy stocks are in the red. This morning, Sangamo Therapeutics ( SGMO -21.1% ) reported data on SB-913 that disappointed investors. More news on: Sangamo Therapeutics, Inc., AVROBIO, MeiraGTx Holdings plc, Healthcare stocks news, Stocks ...
Source: SeekingAlpha
Date: September, 05 2018 10:58
uniQure to Participate at Multiple Upcoming Conferences
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Aug. 30, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming conferenc...
Source: Thomson Reuters ONE
Date: August, 30 2018 07:00
uniQure Makes Substantial Progress Towards A Large Hemophilia B Market
Recently, uniQure ( QURE ) announced that it had dosed its first patient for its phase 2b dose-confirmation study treating patients with hemophilia B. In addition, the biotech has also already started recruiting patients for its phase 3 HOPE-B clinical study. This is a very promising program...
Source: SeekingAlpha
Date: August, 27 2018 13:29

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1441.7541.2542.83941.08188,027
2018-05-2132.2831.5032.4931.37299,051
2018-05-1830.9431.3131.5230.93300,838
2018-05-1732.3230.8332.557930.48353,939
2018-05-1631.9832.4033.2031.73348,346

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0777,958126,01461.8646Short
2018-12-0674,050229,90132.2095Cover
2018-12-0456,562120,91446.7787Short
2018-12-0367,322152,48644.1496Short
2018-11-3026,90355,34848.6070Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on QURE.


About uniQure N.V. (NASDAQ: QURE)

Logo for uniQure N.V. (NASDAQ: QURE)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: QURE)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 21 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 08 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 08 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: June, 15 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: June, 14 2018
      Automatic shelf registration statement of securities of well-known seasoned issuers
      Filing Type: S-3ASRFiling Source: edgar
      Filing Date: June, 14 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: May, 31 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: May, 16 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: May, 16 2018
      Amendment to a SC 13D filing
      Filing Type: SC 13D/AFiling Source: edgar
      Filing Date: May, 09 2018

       

       


      Daily Technical Chart for (NASDAQ: QURE)

      Daily Technical Chart for (NASDAQ: QURE)


      Stay tuned for daily updates and more on (NASDAQ: QURE)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: QURE)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in QURE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of QURE and does not buy, sell, or trade any shares of QURE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/